跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RENVELA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
RENVELA
Authorized
STANDARD
RENVELA
sanofi-aventis canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
4714e07b258b3427
Company
sanofi-aventis canada inc
Type
Standard
Approval Details
Approval Id
4714e07b258b3427
Drug Approval Canada Name
RENVELA
Product Name
RENVELA
Status
Cancelled Post Market
Status Date
2025-04-10
Original Market Date
2019-10-25
Din
02485567
Drug Class
Human
Dosage Form
Powder For Suspension
Route Of Administration
Oral
Schedule
Prescription
Ahfs
40:18.19
Atc Original
V03AE02 SEVELAMER
Atc Name
v 03 ae 02
Aig Number
0152763003
Company Name
sanofi-aventis canada inc
Company Address
1755 Steeles Avenue West, Toronto, Ontario, Canada, M2R 3T4
Active Ingredients
SEVELAMER CARBONATE
2.4 G / SACHET
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
4714e07b258b3427
Type
Standard
Back to Health Canada Approvals